Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial

Daniela Cardinale, Fabio Ciceri, Roberto Latini, +134

European Journal of Cancer

International Cardiooncology Society-onePreventive MedicineCardiovascular DiseasePharmacologyClinical Trials +7

Bendamustine in Combination With Gemcitabine and Vinorelbine Is an Effective Regimen As Induction Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma: Final Results of a Multicenter Phase II Study

Armando Santoro, Rita Mazza, Alessandro Pulsoni, +15

Journal of Clinical Oncology

RG6234, a GPRC5DxCD3 T-Cell Engaging Bispecific Antibody, Is Highly Active in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Updated Intravenous (IV) and First Subcutaneous (SC) Results from a Phase I Dose-Escalation Study

Carmelo Carlo‐Stella, Rita Mazza, Salomon Manier, +32

Blood

Predictive value of early 18F‐fluorodeoxyglucose positron emission tomography (FDG‐PET) during salvage chemotherapy in relapsing/refractory Hodgkin lymphoma (HL) treated with high‐dose chemotherapy

Luca Castagna, Stéfania Bramanti, Monica Balzarotti, +11

British Journal of Haematology

Oncologic ImagingPet-mriPathologyPredictive ValueGlioma +15

Five-year results of the BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma

Armando Santoro, Rita Mazza, Alessandro Pulsoni, +16

Blood Advances

Brentuximab Vedotin in Patients With Hodgkin Lymphoma and a Failed Allogeneic Stem Cell Transplantation: Results From a Named Patient Program at Four Italian Centers

Carmelo Carlo‐Stella, Francesca Ricci, Serena Dalto, +9

The Oncologist

Tandem high‐dose chemotherapy and autologous stem cell transplantation in refractory/relapsed Hodgkin's lymphoma: A monocenter prospective study

Luca Castagna, Massimo Magagnoli, Monica Balzarotti, +9

American Journal of Hematology

Acute megakaryocytic leukemia in essential thrombocythemia: an unusual evolution?

Franca Radaelli, Rita Mazza, Elisabetta Curioni, +3

European Journal Of Haematology

Hematological MalignancyAutoimmune DiseaseEssential ThrombocythemiaMixed-phenotype Acute LeukemiaEt Patients +13

Allogeneic Stem Cell Transplantation Compared with Chemotherapy for Poor-Risk Hodgkin Lymphoma

Luca Castagna, Barbara Sarina, Elisabetta Todisco, +10

Biology of Blood and Marrow Transplantation

Lymphoid NeoplasiaCell TherapyTransplantationMarrow TransplantationMedicine +12

Dimension of Residual CT Scan Mass in Hodgkin's Lymphoma (HL) Is a Negative Prognostic Factor in Patients with PET Negative After Chemo+/− Radiotherapy

Massimo Magagnoli, Katia Marzo, Monica Balzarotti, +9

Blood